Top 10 Pharmaceutical Companies in UAE 2026
From Julphar and Arcera to LIFEPharma and NewBridge, here are the top 10 pharmaceutical companies in UAE for 2026, with verified facts and recent deals.

For years, the UAE was known as a place where medicines arrived, not where they were made.
That’s starting to change. Slowly, then quickly.
Factories in Ras Al Khaimah, Dubai and Abu Dhabi now ship tablets, insulin and injectables to markets across the Middle East, Africa and beyond. Sovereign investors are building life sciences groups. A Swiss distributor has just agreed to pay US$390 million for a Dubai-based drug platform. And the regulator is keeping score: in the first half of 2026, the Emirates Drug Establishment approved 942 medical products, and 247 of them, more than a quarter, were made locally.
So who is actually doing the work? A few manufacture at scale, while others specialize in bringing new therapies to the region or keeping hospital and pharmacy shelves stocked.
We ranked these companies on manufacturing footprint, market reach, regulatory standing, recent investment and their role in the UAE’s push for medicine security. No company paid to be included.
This guide looks at the top 10 pharmaceutical companies in UAE for 2026, from listed manufacturers to specialist importers and distributors.
Why the UAE Is Building Its Own Pharmaceutical Industry
For pharmaceutical companies in UAE, local production is no longer a side project. It’s part of national policy, and the reasons are practical.
Medicine Security
The pandemic showed how fragile long supply chains can be. Making essential medicines at home reduces the risk of shortages when global shipping or trade breaks down. That’s why the Emirates Drug Establishment now combines regulation, manufacturing oversight and quality control under one roof.
A Growing Manufacturing Base
The Emirates Drug Establishment has licensed 37 facilities to produce human pharmaceutical and medical products. Free zones such as Dubai Science Park, Jebel Ali Free Zone and Khalifa Economic Zones Abu Dhabi (KEZAD) give manufacturers land, logistics and port access in one place.
A Gateway to Nearby Markets
The UAE sits within a few hours’ flight of the GCC, Africa, South Asia and Eastern Europe. Many pharmaceutical companies in UAE use the country as a hub, manufacturing or warehousing here and then exporting across the region.
Access to Newer Therapies
Specialist firms license innovative medicines from American and European drugmakers and register them in the region. That shortens the wait for patients who need oncology, rare-disease and other specialty treatments.
Top 10 Pharmaceutical Companies in UAE at a Glance
| Rank | Name | Core segment | Key 2026 figure |
|---|---|---|---|
| 1 | Julphar | Generics, insulin and consumer health manufacturing | FY2025 revenue of AED 1,075.5 million, up 8.4% |
| 2 | Arcera | Life sciences holding company (Acino, Amoun, Birgi Mefar) | More than 2,000 branded medicines |
| 3 | Neopharma | Pharmaceutical manufacturing and contract production | 10 manufacturing facilities on three continents |
| 4 | Globalpharma | Generic medicines manufacturing | More than 120 products, 40 million packs a year |
| 5 | LIFEPharma | FDA-approved generics manufacturing | AED 700 million KEZAD platform announced |
| 6 | NewBridge Pharmaceuticals | Specialty and rare-disease commercialization | US$390 million DKSH acquisition agreed |
| 7 | Modern Pharmaceutical Company | Pharmaceutical distribution and healthcare services | Operating since 1969 |
| 8 | Shalina Healthcare | Branded generics for African markets | More than 265 products |
| 9 | Al Hayat Pharmaceuticals | Pharmaceutical import and distribution | Operating since 1982 |
| 10 | Hayat Biotech | Vaccines, biosimilars and contract manufacturing | 200 million vials a year capacity at KEZAD |
Top 10 Pharmaceutical Companies in UAE (2026)
Here is how the leading names compare, starting with the country’s best-known drugmaker.
1. Julphar
Julphar, officially Gulf Pharmaceutical Industries, was founded in 1980 and is headquartered in Ras Al Khaimah. It is listed on the Abu Dhabi Securities Exchange, employs about 3,000 people and runs 10 internationally accredited manufacturing facilities. Its business is organized around three areas: Julphar Diabetes Solutions, General Medicines and the consumer division Julphar Life.
The company has a commercial presence in more than 40 countries across five continents and builds on decades of experience in insulin and biologics manufacturing. For 2025, Julphar reported revenue of AED 1,075.5 million, up 8.4%, and EBITDA from continuing operations of AED 109.4 million, up 22.2%. In 2025, CEO Basel Ziyadeh also announced plans to invest Dh300 million over five years to expand manufacturing and localize advanced pharmaceutical technologies.
Key Pharmaceutical Solutions
✔ Julphar Diabetes Solutions – insulin and diabetes care
✔ General Medicines – branded generics across therapy areas
✔ Julphar Life – consumer health products
✔ Export supply to more than 40 countries
Best for: Hospitals, governments and distributors looking for a long-established, UAE-made medicine supplier.
2. Arcera
Arcera is the Abu Dhabi-headquartered life sciences holding company that ADQ launched in 2024. It brings together Swiss drugmaker Acino, Egypt’s Amoun Pharmaceutical Company and Türkiye’s Birgi Mefar Group. At launch, the group listed manufacturing sites in the UAE, Switzerland, Ukraine, Estonia, South Africa, Türkiye and Egypt.
The UAE link runs through Acino, which in 2023 completed its integration of Dubai-based Pharmax Pharmaceuticals and its GCC and EU GMP-certified manufacturing site. Today, Arcera reports more than 2,000 branded medicines and more than 6,000 employees, with operations in over 60 countries. Its priority areas include cardiometabolism, neurosciences, gastroenterology, oncology, immunology and rare diseases, and it has signed licensing deals such as an agreement for AriBio’s Alzheimer’s candidate AR1001.
Key Pharmaceutical Solutions
✔ Branded generics through Acino and Amoun
✔ Sterile injectables through Birgi Mefar
✔ In-licensing of innovative therapies
✔ Manufacturing in the UAE and six other countries
Best for: Partners seeking a sovereign-backed group with broad reach across emerging markets.
3. Neopharma
Founded in 2003, Neopharma is one of the UAE’s leading pharmaceutical manufacturers. The company operates 10 manufacturing facilities across three continents and supplies medicines to more than 50 international markets.
Its strengths lie in partnership manufacturing. Neopharma has worked with global companies including Pfizer and Merck, producing medicines under agreements that bring international standards and technology into the UAE. The company has also expanded abroad over the years, including a plant in Japan bought from Cosmo Oil Co. In September 2026, Neopharma held talks with Turkmenistan on pharmaceutical cooperation, a sign that it continues to look for new markets. That reach makes it one of the more internationally active pharmaceutical companies in UAE.
Key Pharmaceutical Solutions
✔ Contract and partnership manufacturing
✔ Generic and branded medicines
✔ Supply to more than 50 markets
✔ Multi-country production network
Best for: Global drugmakers looking for a UAE manufacturing partner with international experience.
4. Globalpharma
Globalpharma is a Dubai-based generic medicines manufacturer and a wholly owned subsidiary of Dubai Investments, which is listed on the Dubai Financial Market. The company has been fully locally owned since 2019. It makes more than 120 pharmaceutical products and produces about 40 million medicine packs a year from two UAE plants, covering general and penicillin-based treatments.
Globalpharma exports to more than 12 countries across Africa, the GCC, Eastern Europe and Asia. It announced plans for 25 new product launches in 2025 and signed agreements including a biosimilar partnership with Jordan’s PharmaPrimes and a licensing deal with Canada’s BioSyent Pharma for FeraMAX. It is also preparing to make generic GLP-1 medicines such as semaglutide once patents and approvals allow. In September 2026, it signed an MoU with PrinceFarma to expand distribution in Angola.
Key Pharmaceutical Solutions
✔ Generic tablets, capsules and syrups
✔ Penicillin-based treatments
✔ Biosimilar and licensing partnerships
✔ Exports to more than 12 countries
Best for: Buyers looking for affordable, Dubai-made generics.
5. LIFEPharma
LIFEPharma is a wholly owned subsidiary of Abu Dhabi-based VPS Healthcare, founded by Dr Shamsheer Vayalil. Its manufacturing plant is in Jebel Ali, and the company is described as the only US Food and Drug Administration-approved pharmaceutical manufacturer in the UAE.
That approval gives LIFEPharma access to some of the hardest markets to enter, and the company already exports medicines to the US, Canada and Australia. In 2026, at Make it in the Emirates, it announced an AED 700 million (about US$190 million) manufacturing platform at KEZAD in Abu Dhabi under an MoU with AD Ports Group. The plan covers a vaccine fill-and-finish facility, an oncology unit and advanced injectables such as peptides and biologics. The project is expected to create more than 1,000 skilled jobs.
Key Pharmaceutical Solutions
✔ US FDA-approved generic manufacturing
✔ Exports to North America and Australia
✔ Planned vaccine fill-and-finish facility
✔ Planned oncology and injectables units
Best for: Partners that need FDA-standard production from the UAE.
6. NewBridge Pharmaceuticals
Founded in 2010 and headquartered in Dubai, NewBridge Pharmaceuticals is a specialty company that brings innovative medicines to the Middle East and North Africa. It in-licenses and commercializes therapies approved by the FDA or EMA that are not yet available in the region. The company has more than 300 employees.
NewBridge works across 14 MENA markets, with Saudi Arabia and the UAE among the largest, and focuses on oncology, neurology, immunology and gastroenterology, along with rare diseases. Its success has attracted interest from abroad. In October 2026, Swiss group DKSH agreed to acquire 100% of NewBridge at an enterprise value of US$390 million. The deal is expected to close by the end of the first quarter of 2027, subject to approvals, and NewBridge’s management is set to stay on.
Key Pharmaceutical Solutions
✔ In-licensing of FDA- and EMA-approved therapies
✔ Regulatory registration and market access
✔ Specialty and rare-disease launches
✔ Commercial coverage across 14 markets
Best for: International drugmakers launching specialty medicines in the Middle East.
7. Modern Pharmaceutical Company
Modern Pharmaceutical Company (MPC) was established in 1969 as a retail pharmacy and is headquartered in Dubai Healthcare City. It belongs to Albatha Group, which describes itself as one of the UAE’s largest conglomerates, through the Albatha Healthcare Group division.
Over more than five decades, MPC has grown into one of the UAE’s major pharmaceutical distributors and healthcare service providers, supplying pharmacies, hospitals, health centers and institutions across the country. Its business covers PharmaConsumer, Medical, Patient and Customer, and Supply Chain areas. For international principals, MPC offers services ranging from regulatory support and warehousing to order fulfillment and sales and marketing. Few pharmaceutical companies in UAE have served the domestic market for as long.
Key Pharmaceutical Solutions
✔ Pharmaceutical and consumer health distribution
✔ Regulatory support for principals
✔ Warehousing and logistics
✔ Sales and marketing support
Best for: International manufacturers needing an experienced UAE distribution partner.
8. Shalina Healthcare
Shalina Healthcare is a privately owned pharmaceutical company headquartered in Dubai. Founded by the Virji family, it marked 40 years in Africa in 2024 and focuses on bringing affordable, quality medicines to African patients.
The company offers more than 265 products, from prescription medicines to consumer health, in generic and branded generic forms. Its main therapy areas are anti-malarials, antibiotics, anti-inflammatories and nutrition. Shalina has a strong presence in Nigeria, Zambia, Angola, Ghana and Kenya, among other countries, and has recently moved into healthcare services with Shalina Diagnostics. In 2020, it also took a stake in Kenya’s Pharmaceutical Manufacturing Company. Run from Dubai, it shows how UAE-based pharmaceutical companies can reach markets far beyond the Gulf.
Key Pharmaceutical Solutions
✔ Anti-malarials and antibiotics
✔ Anti-inflammatories and nutrition products
✔ Branded generics for African markets
✔ Shalina Diagnostics services
Best for: Partners targeting affordable medicine access in Africa.
9. Al Hayat Pharmaceuticals
Established in 1982, Al Hayat Pharmaceuticals is headquartered in Sharjah, with offices in Dubai and Abu Dhabi. It is one of the longer-serving medicine importers and distributors in the country.
The company is an approved supplier to several major UAE government and healthcare entities and acts as exclusive distributor for a number of international manufacturers. That role matters. Companies like Al Hayat handle the registration, storage and delivery that keep those products available in hospitals and pharmacies. Its presence across three emirates gives it reach into both public and private healthcare. For foreign manufacturers entering the country, an experienced local distributor can make the difference between a smooth launch and a slow one.
Key Pharmaceutical Solutions
✔ Exclusive distribution for international manufacturers
✔ Supply to government and healthcare entities
✔ Offices in Sharjah, Dubai and Abu Dhabi
✔ Pharmaceutical import and logistics
Best for: Overseas manufacturers seeking an established UAE distributor.
10. Hayat Biotech
Hayat Biotech is an Abu Dhabi-based joint venture between G42 and Sinopharm CNBG. It focuses on life sciences R&D, vaccine production, biosimilars, pharmaceuticals and contract manufacturing.
The company produced Hayat-Vax, described as the first Covid-19 vaccine made in the Arab world, and said it delivered 36 million doses across 64 countries during the pandemic. Its Life Sciences Park in KEZAD was built with capacity for 200 million vials and pre-filled syringes a year, and in 2023 it reported combined capacity of 230 million vials across its Abu Dhabi and Belgrade facilities. Hayat Biotech also works with the Department of Health – Abu Dhabi on research, clinical trials and manufacturing, and has signed a supply chain agreement with AD Ports Group to support its global expansion.
Key Pharmaceutical Solutions
✔ Human and animal vaccines
✔ Biosimilars and pharmaceuticals
✔ Contract manufacturing
✔ Clinical research partnerships
Best for: Biopharma companies looking for vaccine and sterile production capacity in the UAE.
How to Choose the Right Pharmaceutical Partner in UAE
Choosing between pharmaceutical companies in UAE takes more than a good brochure. A reliable supply record matters more. Here’s what to check before signing.
Confirm Licensing and Registration
Every medicine sold in the UAE must be registered with the federal regulator, now the Emirates Drug Establishment. Health authorities such as the Department of Health – Abu Dhabi and the Dubai Health Authority also oversee facilities in their emirates. Ask partners which approvals they hold and for which products.
Check Manufacturing Standards
Look for GMP certification and, where relevant, approvals from foreign regulators. An EU GMP or US FDA approval tells you a plant has passed some of the toughest inspections in the industry.
Match the Partner to the Job
A manufacturer, an in-licensing specialist and a distributor do very different work. Decide whether you need production capacity, market access for a new therapy or distribution coverage, and shortlist accordingly.
Look at Market Reach
If you plan to sell beyond the UAE, check which countries a partner already supplies. Existing registrations in the GCC, Africa or other regions can save years of work.
Ask About Supply Reliability
Find out how a partner will get products to you, and how it handles stock, cold chain and shortages. Hospitals and pharmacies care most about whether a product is on the shelf when patients need it.
Frequently Asked Questions About Pharmaceutical Companies in UAE
Which is the best pharmaceutical company in UAE?
There’s no single best choice for everyone. Julphar is one of the longest-established UAE manufacturers, Arcera has one of the broadest international portfolios, and NewBridge specializes in in-licensing. Each company above helps with something different, so the right fit depends on whether you need manufacturing, market access or distribution.
Who regulates medicines in the UAE?
The Emirates Drug Establishment is the federal regulator for medicines and medical products. It combines regulation, manufacturing oversight and quality control, while local authorities such as the Department of Health – Abu Dhabi and the Dubai Health Authority license healthcare facilities in their emirates.
How much medicine is made locally in the UAE?
Local production is growing. In the first half of 2026, the Emirates Drug Establishment approved 942 medical products, and 247 of them, about 26%, were made in the UAE.
Are there US FDA-approved drug manufacturers in the UAE?
Yes. LIFEPharma, part of VPS Healthcare, is described as the only US FDA-approved pharmaceutical manufacturer in the UAE and exports medicines to the US, Canada and Australia.
Conclusion
The top pharmaceutical companies in UAE now cover the full chain, from listed manufacturers and sovereign-backed groups to specialist in-licensers and distributors that have served the country for decades. Each plays a different part in keeping medicines available and affordable.
For buyers and partners, the choice comes down to the job at hand: production capacity, regulatory reach, specialty expertise or distribution coverage. What the strongest names share is a clear record of approvals, supply and growth, and that’s what puts them on this list for 2026.

Chirag Thakur
Editor, Business News · CEO Review Magazine
Chirag Thakur covers business news for CEO Review Magazine, along with markets, technology and industry explainers and the magazine's Top 10 rankings of companies and leaders.



